TradeWorx’s BioCryst Pharmaceuticals BCRX Stock Holding History

TradeWorx’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-37,343	Closed	-$284K	–	347
2013 Q4	$284K	Buy	+37,343	New	+$236K	0.12%	283

Other funds holding BCRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

TradeWorx's BCRX Position: Q1 2014 in Review

TradeWorx sold out of BioCryst Pharmaceuticals (BCRX) in Q1 2014, closing a stake of 37,343 shares — an estimated $284K sold.

TradeWorx first reported a position in BCRX in Q4 2013 and held it in 1 quarter. The position peaked at $284K in Q4 2013. 88 funds tracked by Wall St. Rank hold BCRX as of Q1 2014.

TradeWorx reported no remaining BioCryst Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
TradeWorx sold 37,343 BioCryst Pharmaceuticals shares in Q1 2014, an estimated $284K.
TradeWorx first reported a position in BioCryst Pharmaceuticals in Q4 2013 and held it in 1 quarter.
TradeWorx's BioCryst Pharmaceuticals position peaked at $284K in Q4 2013.
88 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2014.

Based on TradeWorx's 13F filing for Q1 2014, filed 2 Jun 2014.